Cargando…

Serum differential proteomic profiling of patients with isolated methylmalonic acidemia by iTRAQ

Isolated methylmalonic acidemia (MMA) is an inherited organic acid metabolic disorder in an autosomal recessive manner, caused by mutations in the methylmalonyl coenzyme A mutase gene, and the isolated MMA patients often suffer from multi-organ damage. The present study aimed to profile the differen...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Sitao, Shi, Congcong, Cai, Yao, Gu, Xia, Xiong, Hui, Liu, Xiaoyu, Zhang, Yinchun, Xiao, Xin, Ma, Fei, Hao, Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464863/
https://www.ncbi.nlm.nih.gov/pubmed/36105101
http://dx.doi.org/10.3389/fgene.2022.765637
_version_ 1784787664385343488
author Li, Sitao
Shi, Congcong
Cai, Yao
Gu, Xia
Xiong, Hui
Liu, Xiaoyu
Zhang, Yinchun
Xiao, Xin
Ma, Fei
Hao, Hu
author_facet Li, Sitao
Shi, Congcong
Cai, Yao
Gu, Xia
Xiong, Hui
Liu, Xiaoyu
Zhang, Yinchun
Xiao, Xin
Ma, Fei
Hao, Hu
author_sort Li, Sitao
collection PubMed
description Isolated methylmalonic acidemia (MMA) is an inherited organic acid metabolic disorder in an autosomal recessive manner, caused by mutations in the methylmalonyl coenzyme A mutase gene, and the isolated MMA patients often suffer from multi-organ damage. The present study aimed to profile the differential proteome of serum between isolated MAA patients and healthy control. The in vivo proteome of isolated MAA patients and healthy subjects was detected by an isobaric tag for relative and absolute quantitation (iTRAQ). A total of 94 differentially expressed proteins (DEPs) were identified between MMA patients and healthy control, including 58 upregulated and 36 downregulated DEPs in MMA patients. Among them, the most significantly upregulated proteins were CRP and immunoglobulins, and the top five most significantly downregulated proteins were all different types of immunoglobulins in MMA patients. GO analysis showed that these DEPs were mainly enriched in immune-related function and membrane protein-related function. KEGG revealed that these DEPs were mainly enriched in lysosome and cholesterol metabolism pathways. Also, these DEPs were predicted to contribute to lipid metabolic diseases. We addressed the proteomes of isolated MMA patients and identified DEPs. Our study expands our current understanding of MMA, and the DEPs could be valuable for designing alternative therapies to alleviate MMA symptoms.
format Online
Article
Text
id pubmed-9464863
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94648632022-09-13 Serum differential proteomic profiling of patients with isolated methylmalonic acidemia by iTRAQ Li, Sitao Shi, Congcong Cai, Yao Gu, Xia Xiong, Hui Liu, Xiaoyu Zhang, Yinchun Xiao, Xin Ma, Fei Hao, Hu Front Genet Genetics Isolated methylmalonic acidemia (MMA) is an inherited organic acid metabolic disorder in an autosomal recessive manner, caused by mutations in the methylmalonyl coenzyme A mutase gene, and the isolated MMA patients often suffer from multi-organ damage. The present study aimed to profile the differential proteome of serum between isolated MAA patients and healthy control. The in vivo proteome of isolated MAA patients and healthy subjects was detected by an isobaric tag for relative and absolute quantitation (iTRAQ). A total of 94 differentially expressed proteins (DEPs) were identified between MMA patients and healthy control, including 58 upregulated and 36 downregulated DEPs in MMA patients. Among them, the most significantly upregulated proteins were CRP and immunoglobulins, and the top five most significantly downregulated proteins were all different types of immunoglobulins in MMA patients. GO analysis showed that these DEPs were mainly enriched in immune-related function and membrane protein-related function. KEGG revealed that these DEPs were mainly enriched in lysosome and cholesterol metabolism pathways. Also, these DEPs were predicted to contribute to lipid metabolic diseases. We addressed the proteomes of isolated MMA patients and identified DEPs. Our study expands our current understanding of MMA, and the DEPs could be valuable for designing alternative therapies to alleviate MMA symptoms. Frontiers Media S.A. 2022-08-29 /pmc/articles/PMC9464863/ /pubmed/36105101 http://dx.doi.org/10.3389/fgene.2022.765637 Text en Copyright © 2022 Li, Shi, Cai, Gu, Xiong, Liu, Zhang, Xiao, Ma and Hao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Li, Sitao
Shi, Congcong
Cai, Yao
Gu, Xia
Xiong, Hui
Liu, Xiaoyu
Zhang, Yinchun
Xiao, Xin
Ma, Fei
Hao, Hu
Serum differential proteomic profiling of patients with isolated methylmalonic acidemia by iTRAQ
title Serum differential proteomic profiling of patients with isolated methylmalonic acidemia by iTRAQ
title_full Serum differential proteomic profiling of patients with isolated methylmalonic acidemia by iTRAQ
title_fullStr Serum differential proteomic profiling of patients with isolated methylmalonic acidemia by iTRAQ
title_full_unstemmed Serum differential proteomic profiling of patients with isolated methylmalonic acidemia by iTRAQ
title_short Serum differential proteomic profiling of patients with isolated methylmalonic acidemia by iTRAQ
title_sort serum differential proteomic profiling of patients with isolated methylmalonic acidemia by itraq
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464863/
https://www.ncbi.nlm.nih.gov/pubmed/36105101
http://dx.doi.org/10.3389/fgene.2022.765637
work_keys_str_mv AT lisitao serumdifferentialproteomicprofilingofpatientswithisolatedmethylmalonicacidemiabyitraq
AT shicongcong serumdifferentialproteomicprofilingofpatientswithisolatedmethylmalonicacidemiabyitraq
AT caiyao serumdifferentialproteomicprofilingofpatientswithisolatedmethylmalonicacidemiabyitraq
AT guxia serumdifferentialproteomicprofilingofpatientswithisolatedmethylmalonicacidemiabyitraq
AT xionghui serumdifferentialproteomicprofilingofpatientswithisolatedmethylmalonicacidemiabyitraq
AT liuxiaoyu serumdifferentialproteomicprofilingofpatientswithisolatedmethylmalonicacidemiabyitraq
AT zhangyinchun serumdifferentialproteomicprofilingofpatientswithisolatedmethylmalonicacidemiabyitraq
AT xiaoxin serumdifferentialproteomicprofilingofpatientswithisolatedmethylmalonicacidemiabyitraq
AT mafei serumdifferentialproteomicprofilingofpatientswithisolatedmethylmalonicacidemiabyitraq
AT haohu serumdifferentialproteomicprofilingofpatientswithisolatedmethylmalonicacidemiabyitraq